• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《回到未来:从神经毒素诱导的帕金森病模型到人类帕金森病模型》

Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.

作者信息

Airavaara Mikko, Parkkinen Ilmari, Konovalova Julia, Albert Katrina, Chmielarz Piotr, Domanskyi Andrii

机构信息

Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.

出版信息

Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88.

DOI:10.1002/cpns.88
PMID:32049438
Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by motor symptoms such as tremor, slowness of movement, rigidity, and postural instability, as well as non-motor features like sleep disturbances, loss of ability to smell, depression, constipation, and pain. Motor symptoms are caused by depletion of dopamine in the striatum due to the progressive loss of dopamine neurons in the substantia nigra pars compacta. Approximately 10% of PD cases are familial arising from genetic mutations in α-synuclein, LRRK2, DJ-1, PINK1, parkin, and several other proteins. The majority of PD cases are, however, idiopathic, i.e., having no clear etiology. PD is characterized by progressive accumulation of insoluble inclusions, known as Lewy bodies, mostly composed of α-synuclein and membrane components. The cause of PD is currently attributed to cellular proteostasis deregulation and mitochondrial dysfunction, which are likely interdependent. In addition, neuroinflammation is present in brains of PD patients, but whether it is the cause or consequence of neurodegeneration remains to be studied. Rodents do not develop PD or PD-like motor symptoms spontaneously; however, neurotoxins, genetic mutations, viral vector-mediated transgene expression and, recently, injections of misfolded α-synuclein have been successfully utilized to model certain aspects of the disease. Here, we critically review the advantages and drawbacks of rodent PD models and discuss approaches to advance pre-clinical PD research towards successful disease-modifying therapy. © 2020 The Authors.

摘要

帕金森病(PD)是一种与年龄相关的神经退行性疾病,其特征包括震颤、运动迟缓、僵硬和姿势不稳等运动症状,以及睡眠障碍、嗅觉丧失、抑郁、便秘和疼痛等非运动特征。运动症状是由于黑质致密部多巴胺能神经元逐渐丧失,导致纹状体中多巴胺耗竭所致。约10%的帕金森病病例为家族性,由α-突触核蛋白、LRRK2、DJ-1、PINK1、parkin和其他几种蛋白质的基因突变引起。然而,大多数帕金森病病例是特发性的,即没有明确的病因。帕金森病的特征是不可溶性包涵体(称为路易小体)的逐渐积累,其主要由α-突触核蛋白和膜成分组成。目前,帕金森病的病因被认为是细胞蛋白质稳态失调和线粒体功能障碍,这两者可能相互依存。此外,帕金森病患者大脑中存在神经炎症,但其是神经退行性变的原因还是结果仍有待研究。啮齿动物不会自发出现帕金森病或类似帕金森病的运动症状;然而,神经毒素、基因突变、病毒载体介导的转基因表达以及最近注射错误折叠的α-突触核蛋白已成功用于模拟该疾病的某些方面。在此,我们批判性地回顾了啮齿动物帕金森病模型的优缺点,并讨论了推进临床前帕金森病研究以实现成功的疾病修饰治疗的方法。© 2020作者。

相似文献

1
Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.《回到未来:从神经毒素诱导的帕金森病模型到人类帕金森病模型》
Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88.
2
Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.帕金森病神经毒素 MPTP 剂量相关的双相作用,对α-突触核蛋白的传播、积累和毒性的影响。
Neurotoxicology. 2021 May;84:41-52. doi: 10.1016/j.neuro.2021.02.001. Epub 2021 Feb 4.
3
Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.神经毒素诱导的帕金森病啮齿动物模型:优缺点。
Neurotox Res. 2021 Jun;39(3):897-923. doi: 10.1007/s12640-021-00356-8. Epub 2021 Mar 25.
4
Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.帕金森病相关基因突变小鼠的行为和神经化学增强令人惊讶。
Neurobiol Dis. 2014 Feb;62:113-23. doi: 10.1016/j.nbd.2013.09.009. Epub 2013 Sep 26.
5
DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.DJ-1 蛋白可保护多巴胺能神经元免受 6-OHDA/MG-132 诱导的大鼠神经毒性。
Brain Res Bull. 2012 Sep 1;88(6):609-16. doi: 10.1016/j.brainresbull.2012.05.013. Epub 2012 Jun 1.
6
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.α-突触核蛋白致密聚集体的耗散与一种新的帕金森病模型中多巴胺能神经元功能障碍和死亡的挽救有关。
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
7
Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.在小鼠中长期给予胆固醇肟可增加细胞保护基因的转录,并改善黑质纹状体多巴胺能神经元中由α-突触核蛋白过表达诱导的转录组改变。
Neurobiol Dis. 2014 Sep;69:263-75. doi: 10.1016/j.nbd.2014.05.012. Epub 2014 May 18.
8
Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.帕金森病与α-突触核蛋白病:从发病机制到治疗挑战
Cent Nerv Syst Agents Med Chem. 2015;15(2):109-16. doi: 10.2174/1871524915666150421114338.
9
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.慢性轻度肠道炎症加速 α-突触核蛋白突变小鼠的脑神经病理学和运动功能障碍。
Neuromolecular Med. 2019 Sep;21(3):239-249. doi: 10.1007/s12017-019-08539-5. Epub 2019 May 11.
10
Modeling Parkinson's Disease in C. elegans.线虫中帕金森病的建模。
J Parkinsons Dis. 2018;8(1):17-32. doi: 10.3233/JPD-171258.

引用本文的文献

1
The GBA1 K198E Variant Is Associated with Suppression of Glucocerebrosidase Activity, Autophagy Impairment, Oxidative Stress, Mitochondrial Damage, and Apoptosis in Skin Fibroblasts.GBA1 K198E 变异与葡萄糖脑苷脂酶活性抑制、自噬损伤、氧化应激、线粒体损伤和皮肤成纤维细胞凋亡有关。
Int J Mol Sci. 2024 Aug 25;25(17):9220. doi: 10.3390/ijms25179220.
2
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease.在帕金森病蛋白酶体抑制小鼠模型中,烟酰胺核糖苷最初可缓解症状,但随后会下调多巴胺代谢。
Heliyon. 2024 Jul 9;10(14):e34355. doi: 10.1016/j.heliyon.2024.e34355. eCollection 2024 Jul 30.
3
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.
BDNF/TrkB 激活剂在帕金森病中的作用:一种新的治疗策略。
J Cell Mol Med. 2024 May;28(10):e18368. doi: 10.1111/jcmm.18368.
4
The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review.胆固醇和他汀类药物对帕金森病神经病理学的影响:叙事性综述。
Inflammopharmacology. 2024 Apr;32(2):917-925. doi: 10.1007/s10787-023-01400-z. Epub 2024 Mar 18.
5
Possible role of lncRNAs in amelioration of Parkinson's disease symptoms by transplantation of dopaminergic cells.长链非编码RNA在通过多巴胺能细胞移植改善帕金森病症状中的可能作用。
NPJ Parkinsons Dis. 2024 Mar 12;10(1):56. doi: 10.1038/s41531-024-00661-x.
6
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue.糖原合酶激酶 3β(GSK-3β)抑制剂在帕金森病中的治疗潜力:探索被忽视的途径。
Mol Neurobiol. 2024 Sep;61(9):7092-7108. doi: 10.1007/s12035-024-04003-z. Epub 2024 Feb 17.
7
Neuroprotective effects of polyacrylic acid (PAA) conjugated cerium oxide against hydrogen peroxide- and 6-OHDA-induced SH-SY5Y cell damage.聚甲基丙烯酸(PAA)接枝氧化铈对过氧化氢和 6-羟基多巴胺诱导的 SH-SY5Y 细胞损伤的神经保护作用。
Sci Rep. 2023 Oct 28;13(1):18534. doi: 10.1038/s41598-023-45318-6.
8
The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson's Disease: The Way of New Inroads.p75 神经营养因子受体(p75NTR)在帕金森病中的分子途径:新途径的探索。
Mol Neurobiol. 2024 May;61(5):2469-2480. doi: 10.1007/s12035-023-03727-8. Epub 2023 Oct 28.
9
Longitudinal study of the inverse relationship between Parkinson's disease and cancer in Korea.韩国帕金森病与癌症之间负相关关系的纵向研究。
NPJ Parkinsons Dis. 2023 Jul 22;9(1):116. doi: 10.1038/s41531-023-00562-5.
10
Parkinson's Disease: Exploring Different Animal Model Systems.帕金森病:探索不同的动物模型系统。
Int J Mol Sci. 2023 May 22;24(10):9088. doi: 10.3390/ijms24109088.